摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl {(3R)-1-[2,2-dicyano-1-(methylthio)vinyl]piperidin-3-yl}carbamate | 876176-72-6

中文名称
——
中文别名
——
英文名称
tert-butyl {(3R)-1-[2,2-dicyano-1-(methylthio)vinyl]piperidin-3-yl}carbamate
英文别名
tert-butyl {(3R)-1-[2,2-dicyano-1-(methylthio)vinyl]-piperidin-3-yl}carbamate;tert-butyl N-[(3R)-1-(2,2-dicyano-1-methylsulfanylethenyl)piperidin-3-yl]carbamate
tert-butyl {(3R)-1-[2,2-dicyano-1-(methylthio)vinyl]piperidin-3-yl}carbamate化学式
CAS
876176-72-6
化学式
C15H22N4O2S
mdl
——
分子量
322.431
InChiKey
POXHEFHRYJZSKH-GFCCVEGCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    114
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Bicyclic Pyrrole Derivatives
    申请人:Nakahira Hiroyuki
    公开号:US20080318922A1
    公开(公告)日:2008-12-25
    Compounds represented by the general formula (I), prodrugs thereof, or pharmaceutically acceptable salts of both are provided as compounds which have high DPP-IV inhibiting activity and are improved in safety, toxicity and so on: (I) wherein the solid line and dotted line between A 1 and A 2 represents a double bond (A 1 =A 2 ) or the like; A 1 is C(R 4 ) or the like; A 2 is nitrogen atom or the like; R 1 is hydrogen atom, optionally substituted alkyl group, or the like; R 2 is hydrogen atom, optionally substituted alkyl group, or the like; R 3 is hydrogen atom, halogen atom, or the like; R 4 is hydrogen atom, hydroxyl, halogen atom, or the like; and Y is a group represented by the general formula (A) or the like; (A) [wherein m1 is 0, 1, 2 or 3; and the group (A) may be freed from R 6 or substituted with one or two R 6 's which are each independently halogen atom or the like.]
    提供了一种通式(I)、其前药或两者的药物可接受盐作为具有高DPP-IV抑制活性并在安全性、毒性等方面得到改进的化合物:(I)其中A1和A2之间的实线和虚线表示双键(A1=A2)或类似物;A1是C(R4)或类似物;A2是氮原子或类似物;R1是氢原子、可选取代烷基或类似物;R2是氢原子、可选取代烷基或类似物;R3是氢原子、卤原子或类似物;R4是氢原子、羟基、卤原子或类似物;Y是由通式(A)或类似物表示的基团;(A)[其中m1为0、1、2或3;基团(A)可以从R6中释放或用一个或两个R6替代,它们各自独立地是卤原子或类似物。]
  • Bicyclic pyrrole derivatives
    申请人:Dainippon Sumitomo Pharma Co., Ltd.
    公开号:US07601728B2
    公开(公告)日:2009-10-13
    Compounds represented by the general formula (I), prodrugs thereof, or pharmaceutically acceptable salts of both are provided as compounds which have high DPP-IV inhibiting activity and are improved in safety, toxicity and so on: (I) wherein the solid line and dotted line between A1 and A2 represents a double bond (A1═A2) or the like; A1 is C(R4) or the like; A2 is nitrogen atom or the like; R1 is hydrogen atom, optionally substituted alkly group, or the like; R2 is hydrogen atom, optionally substituted alkyl group, or the like; R3 is hydrogen atom, halogen atom, or the like; R4 is hydrogen atom, hydroxyl, halogen atom, or the like; and Y is a group represented by the general formula (A) or the like; (A) [wherein m1 is 0, 1, 2 or 3; and the group (A) may be freed from R6 or substituted with one or two R6's which are each independently halogen atom or the like.]
    提供了由一般式(I)表示的化合物、其前药或两者的药学上可接受的盐,这些化合物具有高DPP-IV抑制活性,并在安全性、毒性等方面得到改善:(I)其中A1和A2之间的实线和虚线表示双键(A1═A2)或类似物;A1是C(R4)或类似物;A2是氮原子或类似物;R1是氢原子、可选择的取代烷基或类似物;R2是氢原子、可选择的取代烷基或类似物;R3是氢原子、卤原子或类似物;R4是氢原子、羟基、卤原子或类似物;Y是由一般式(A)或类似物表示的基团;(A)[其中m1为0、1、2或3;基团(A)可以从R6中解放出来,或用一个或两个R6取代,这些R6各自独立地是卤原子或类似物。]
  • BICYCLIC PYRROLE DERIVATIVES
    申请人:Nakahira Hiroyuki
    公开号:US20090149483A1
    公开(公告)日:2009-06-11
    Compounds represented by the general formula (I), prodrugs thereof, or pharmaceutically acceptable salts of both are provided as compounds which have high DPP-IV inhibiting activity and are improved in safety, toxicity and so on: (I) wherein the solid line and dotted line between A 1 and A 2 represents a double bond (A 1 =A 2 ) or the like; A 1 is C(R 4 ) or the like; A 2 is nitrogen atom or the like; R 1 is hydrogen atom, optionally substituted alkly group, or the like; R 2 is hydrogen atom, optionally substituted alkyl group, or the like; R 3 is hydrogen atom, halogen atom, or the like; R 4 is hydrogen atom, hydroxyl, halogen atom, or the like; and Y is a group represented by the general formula (A) or the like; (A) [wherein m1 is 0, 1, 2 or 3; and the group (A) may be freed from R 6 or substituted with one or two R 6 's which are each independently halogen atom or the like.]
    提供了一种通式(I)、其前药或其药学上可接受的盐,作为具有高DPP-IV抑制活性并在安全性、毒性等方面得到改善的化合物:(I),其中A1和A2之间的实线和虚线表示双键(A1=A2)或类似结构;A1是C(R4)或类似结构;A2是氮原子或类似结构;R1是氢原子、可选择性取代的烷基或类似结构;R2是氢原子、可选择性取代的烷基或类似结构;R3是氢原子、卤素原子或类似结构;R4是氢原子、羟基、卤素原子或类似结构;Y是由通式(A)或类似结构表示的基团;(A)中,m1为0、1、2或3;且基团(A)可能从R6中解放出来,或被一个或两个独立的R6取代,这些R6分别是卤素原子或类似结构。
  • WO2006/68163
    申请人:——
    公开号:——
    公开(公告)日:——
  • One-pot synthesis of 5-amino 4-cyano pyrrole derivatives
    作者:Yukihiro Nishio、Hidenori Kimura、Katsuya Uchiyama、Yoshihiro Horiuchi、Hiroyuki Nakahira
    DOI:10.1016/j.tetlet.2011.03.080
    日期:2011.5
    One-pot synthesis of 5-amino 4-cyano pyrrole derivatives is herein disclosed. The described method consists of four steps and gives new pyrrole derivatives in moderate to good yields. This synthesis can be used for a large scale preparation. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多